Anticholinergic syndrome following an unintentional overdose of scopolamine

Therapeutics and Clinical Risk Management

Volumn 5, Issue 1, 2009, Pages 719-723

  Corallo, Carmela E ^a   Whitfield, Ann ^b   Wu, Adeline ^b  

^a The Alfred ^*  (Australia)

^b BOX HILL HOSPITAL   (Australia)

Author keywords

Anticholinergic syndrome; Domperidone; Nonprescription drugs; Scopolamine; Toxicity

Indexed keywords

DOMPERIDONE; HERBACEOUS AGENT; LOPERAMIDE; NON PRESCRIPTION DRUG; NUTRACEUTICAL; SCOPOLAMINE;

ADULT; ANTICHOLINERGIC SYNDROME; ARTICLE; AUSTRALIA; BLURRED VISION; BRONCHUS SECRETION; CASE REPORT; CENTRAL NERVOUS SYSTEM DEPRESSION; DISEASE SEVERITY; DROWSINESS; DRUG OVERDOSE; HUMAN; MALE; MOTION SICKNESS; NAUSEA; PREMEDICATION; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; SALIVATION; SINGLE DRUG DOSE; SYMPTOM; TABLET;

EID: 77949454800     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/tcrm.s6732     Document Type: Article

References (28)

1. Bruns JJ. Anticholinergic toxicity. eMedicine. Updated 2008 March 26; cited 2009 January 2. Available from: http://emedicine.medscape.com/article/ 812644-overview.
2. Hall RCW, Feinsilver DL, Holt RE. Anticholinergic psychosis: differential diagnosis and management. Psychosomatics. 1981; 22(7):581-587.
3. Hooper RG, Conner CS, Rumack BH. Acute poisoning from over-the-counter sleep preparations. JACEP. 1979;8:98-100.
4. Van Sassenbrocck D, Hemelsoet D, Vanwalleghem P, et al. Three cases of substitution errors leading to hyoscine hydrobromide overdose. Clin Toxicol (Phila). 2005;43:861-865.
5. Spinks AB, Wasiak J, Villaneuva EV, Bernath V. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2007;3:CD002851.
6. Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit. 2005;27(5):655-665.
7. Clissold SP, Heel RC. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1985;29:189-207.
8. Lauwers LF, Daelemans R, Baute L, Verbraeken H. Scopolamine intoxications. Intens Care Med. 1983;9:283-285.
9. Scopolamine. Drug Facts and Comparisons: Pocket Version [online]. 2008. Saint Louis: Wolters Kluwer Health. Cited 2008 October 20. Available from Wolters Kluwer Health, Inc.
10. AHFS drug information. 2005. In: McEvoy GK, editor. Scopolamine. Bethesda, MD: American Society of Health-System Pharmacists; 2005. pp. 1254-1257.
11. Thomson Healthcare. Anticholinergic poisoning. In: Poisindex System. Cited 2009 July 17. Available from: http://www.thomsonhc.com.
12. Roig C, Rodriquez T, Solans T. Sindrome anticholinergico central secundario a colirio mydriatic. Neurologia. 1990;5(1):33-34.
13. Smith EA, Meloan CE, Pickell JA, Oehme FW. Scopolamine poisoning from homemade 'Moon Flower' wine. J Anal Toxicol. 1991;15:215-219.
14. Goldfrank L, Flomenbaum N, Lewin N, Weisman R, Howland MA, Kaul B. Anticholinergic poisoning. J Toxicol Clin Toxicol. 1982;19(1):17-25.
15. Biggs JT, Spiker DG, Petit JM, Ziegler VE. Tricyclic antidepressant overdose. JAMA. 1977;238(2):135-138.
16. DeFrates LJ, Hoehns JD, Sakombut EL, Glascock DG, Tew AR. Antimuscarinic intoxication resulting from the ingestion of Moonflower seeds. Ann Pharmacother. 2005;39:173-176.
17. Ayub N, Donaldson D, Bedford D, et al. Lessons to be learned: a case study approach. J Roy Soc Health. 1997;117:242-244.
18. McEwen J, Thompson BR, Purcell PM, Kelly LF, Krauss AS. Widespread hyoscine hydrobromide toxicity due t contract manufacturer malpractice: the Travacalm episode. Drug Safety. 2007;30(5):375-378.
19. Samuels SI, Washington E. Coma and abnormal neurologic signs following premedication. Anesth Analg. 1980;59:79-80.
20. Elias M, Abouleish E. Scopolamine patch can be confusing to the patient and anesthesiologist: a case report. Anesthesiology. 1997;86(3):743-744.
21. Chan YC, Tse ML, Lau FL. Two cases of anticholinergic poisoning from transdermal scopolamine patch. Hong Kong Journal of Emergency Medicine. 2006;13(4):221-224.
22. Repéssé X, Geeraerts T, Pottecher J, Vigué B, Benhamou D, Duranteau J. [Coma with bilateral mydriasis after use of transdermal scopolamine in ICU.] Ann Fr Anesth Reanim. 2007;26:1070-1072.
23. Kranke P, Morin AM, Roewer N, Wulf H, Eberhart LH. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2002;95:133-143.
24. Reddymasu S, Soykan I, McCallum W. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007;102:2036-2045.
25. Robinson P. Dosage and drug interactions of domperidone. Am J Gastroenterol. 2008;103:1049.
26. Product information. Kwells (hyoscine hydrobromide). MIMS on-line. NSW: A division of CMPMedia Australia Pty Limited. Cited 2009 July 1. Available from: http://mims.hcn.net.au.
27. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
28. Adverse Drug Reactions Advisory Committee (ADRAC). Travacalm-your reports make a difference! Aust Adv Drug React Bull. 2003;22 (4):15-16. Available from: http://www.tga.gov.au/adr/aadrb/aadr0308.htm.